Listed are the top 10 most common psychiatric diagnoses, based on prevalence, clinical significance, and global impact. These disorders are listed with their DSM-5-TR classification, core features, symptoms, and typical treatment approaches

1. Major Depressive Disorder (MDD)

Category: Depressive Disorders
Prevalence: ~7% annually (U.S.)
Core Features: Persistent sadness or loss of interest

Symptoms:

  • Depressed mood most of the day

  • Anhedonia (loss of interest)

  • Sleep changes

  • Appetite/weight change

  • Fatigue

  • Feelings of worthlessness

  • Difficulty concentrating

  • Suicidal thoughts

Treatment:

  • SSRIs (e.g., fluoxetine)

  • Cognitive Behavioral Therapy (CBT)

  • Lifestyle interventions (exercise, sleep)

  • Electroconvulsive therapy (severe cases)

2. Generalized Anxiety Disorder (GAD)

Category: Anxiety Disorders
Prevalence: ~3% annually

Core Features: Excessive, uncontrollable worry for at least 6 months

Symptoms:

  • Restlessness

  • Fatigue

  • Difficulty concentrating

  • Irritability

  • Muscle tension

  • Sleep disturbance

Treatment:

  • CBT

  • SSRIs or SNRIs

  • Buspirone

  • Relaxation techniques and mindfulness

3. Bipolar I Disorder

Category: Bipolar and Related Disorders
Prevalence: ~1% lifetime

Core Features: At least one manic episode (may include depressive episodes)

Symptoms (Manic Episode):

  • Elevated or irritable mood

  • Increased energy/activity

  • Decreased need for sleep

  • Grandiosity

  • Pressured speech

  • Risky behavior

Treatment:

  • Mood stabilizers (e.g., lithium)

  • Antipsychotics

  • Psychoeducation

  • Therapy (e.g., family-focused)

4. Schizophrenia

Category: Schizophrenia Spectrum and Other Psychotic Disorders
Prevalence: ~1% lifetime

Core Features: Psychosis lasting ≥6 months, including delusions, hallucinations

Symptoms:

  • Positive: delusions, hallucinations, disorganized speech

  • Negative: flat affect, social withdrawal

  • Cognitive: poor executive function

Treatment:

  • Antipsychotics (e.g., risperidone)

  • Psychosocial interventions

  • Supported employment/housing

  • Cognitive remediation therapy

5. Obsessive-Compulsive Disorder (OCD)

Category: Obsessive-Compulsive and Related Disorders
Prevalence: ~1–2% annually

Core Features: Recurrent, intrusive thoughts (obsessions) and repetitive behaviors (compulsions)

Examples:

  • Obsessions: contamination, harm, symmetry

  • Compulsions: hand-washing, checking, counting

Treatment:

  • SSRIs (high doses)

  • Exposure and Response Prevention (ERP)

  • CBT

  • Deep brain stimulation (severe/refractory)

6. Post-Traumatic Stress Disorder (PTSD)

Category: Trauma- and Stressor-Related Disorders
Prevalence: ~3.5% annually

Core Features: Trauma exposure + intrusive memories, avoidance, hyperarousal

Symptoms:

  • Flashbacks/nightmares

  • Avoidance of reminders

  • Negative mood/cognition

  • Hypervigilance, exaggerated startle

Treatment:

  • Trauma-focused CBT

  • EMDR (Eye Movement Desensitization and Reprocessing)

  • SSRIs

  • Prazosin (for nightmares)

7. Attention-Deficit/Hyperactivity Disorder (ADHD)

Category: Neurodevelopmental Disorders
Prevalence: ~5% children, ~2.5% adults

Core Features: Inattention and/or hyperactivity-impulsivity before age 12

Symptoms:

  • Easily distracted

  • Fidgeting

  • Interrupting

  • Poor organization

  • Forgetfulness

Treatment:

  • Stimulants (e.g., methylphenidate)

  • Behavioral therapy

  • School accommodations

  • Parent training

8. Borderline Personality Disorder (BPD)

Category: Personality Disorders (Cluster B)
Prevalence: ~1.6% (up to 5.9% lifetime)

Core Features: Instability in interpersonal relationships, self-image, and affect

Symptoms:

  • Intense fear of abandonment

  • Emotional lability

  • Identity disturbance

  • Impulsivity

  • Self-harm or suicidal behavior

Treatment:

  • Dialectical Behavior Therapy (DBT)

  • Psychodynamic therapy

  • SSRIs (for mood symptoms)

  • Hospitalization (during crises)

9. Social Anxiety Disorder (Social Phobia)

Category: Anxiety Disorders
Prevalence: ~7% annually

Core Features: Fear of social or performance situations

Symptoms:

  • Avoidance of speaking, eating, or performing publicly

  • Fear of embarrassment or humiliation

  • Physical symptoms: blushing, sweating, trembling

Treatment:

  • CBT (exposure therapy)

  • SSRIs or SNRIs

  • Beta-blockers (for performance anxiety)

  • Social skills training

10. Substance Use Disorders (SUDs)

Category: Substance-Related and Addictive Disorders
Prevalence: ~8% annually (any SUD in the U.S.)

Core Features: Problematic use of a substance leading to impairment or distress

Substances:

  • Alcohol, opioids, cannabis, stimulants, etc.

Symptoms:

  • Craving

  • Loss of control

  • Tolerance/withdrawal

  • Continued use despite harm

Treatment:

  • Motivational Interviewing

  • Medication-assisted treatment (e.g., buprenorphine, naltrexone)

  • CBT

  • 12-step programs (e.g., AA)